Re: IP considerations may prevent RVX from disclosing eGFR data

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

cityslicker99

Rank: President [?]

Points: 1942 [?]

Votes: 24 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: IP considerations may prevent RVX from disclosing eGFR data

in response to

IP considerations may prevent RVX from disclosing eGFR data

BKC

posted on Jun 08, 2020 05:43PM

I hope you're right, but I don't understand.

If the company has a patent on apabetalone, why does it need a patent on the drug's effect on GFR (if indeed there is one)?

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply